DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$9.68−0.31 (-3.10%)
Close on Nov 18, 2026Market cap $608.66MP/E –Yield –
DBV Technologies net income
Net income is the profit left for shareholders after every expense, interest and tax.
DBV Technologies's net income for the twelve months ending Sep 30, 2026 was -$207.35M. For fiscal 2025 it was -$146.95M. The highest annual figure on record is $96.27M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$146.95M | – |
| FY2024 | Dec 31, 2024 | -$113.92M | -256.7% |
| FY2023 | Dec 31, 2023 | $72.71M | -24.5% |
| FY2022 | Dec 31, 2022 | $96.27M | – |
| FY2021 | Dec 31, 2021 | -$97.81M | – |
| FY2020 | Dec 31, 2020 | -$159.56M | – |
| FY2019 | Dec 31, 2019 | -$172.01M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$64.50M | – |
| Q2 FY2026 | Jun 30, 2026 | -$50.40M | – |
| Q1 FY2026 | Mar 31, 2026 | -$47.60M | – |
| Q4 FY2025 | Dec 31, 2025 | -$44.85M | – |
| Q3 FY2025 | Sep 30, 2025 | -$33.20M | – |
| Q2 FY2025 | Jun 30, 2025 | -$41.90M | – |
| Q1 FY2025 | Mar 31, 2025 | -$27.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$23.02M | -117.1% |
| Q3 FY2024 | Sep 30, 2024 | -$30.44M | – |
| Q2 FY2024 | Jun 30, 2024 | -$33.12M | – |
| Q1 FY2024 | Mar 31, 2024 | -$27.35M | – |
| Q4 FY2023 | Dec 31, 2023 | $134.25M | -12.4% |
| Q3 FY2023 | Sep 30, 2023 | -$16.74M | – |
| Q2 FY2023 | Jun 30, 2023 | -$24.24M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.56M | – |
| Q4 FY2022 | Dec 31, 2022 | $153.31M | – |
| Q3 FY2022 | Sep 30, 2022 | -$17.29M | – |
| Q2 FY2022 | Jun 30, 2022 | -$23.04M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.71M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.67M | – |
| Q3 FY2021 | Sep 30, 2021 | -$24.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$30.65M | – |
| Q1 FY2021 | Mar 31, 2021 | -$29.45M | – |
| Q4 FY2020 | Dec 31, 2020 | -$39.48M | – |
| Q3 FY2020 | Sep 30, 2020 | -$30.96M | – |
| Q2 FY2020 | Jun 30, 2020 | -$48.20M | – |
| Q1 FY2020 | Mar 31, 2020 | -$40.91M | – |
See a number that looks wrong?